论文部分内容阅读
本文收治年龄、病程相似的原发性高脂血症60例,随机分成2组,分别口服月见草油胶丸1.5gbid和降脂平1片tid共3mo。主要观察胆固醇(TC)、甘油三酯(TG)及β酯蛋白的数据变化。结果月见草油胶丸降血脂有效率为:TC88％、TG91％、β脂蛋白44％;降脂平为:TC30％、TG67％、β脂蛋白76％。说明月见草油胶丸在降低TC及TG方面明显优于降脂平组(P<0.05)。月见草油胶丸停药后,血脂无明显回升,部分病例血脂继续下降,而且不良反应小,是降血脂很有前途的新药,值得推广应用。
This treatise on age, duration of similar primary hyperlipidemia in 60 cases, were randomly divided into two groups, respectively, oral administration of evening primrose oil capsules 1.5gbid and lipid lowering 1 tid a total of 3mo. The main observation of cholesterol (TC), triglyceride (TG) and β-ester protein data changes. The results showed that the effective rates of lowering blood lipid of evening primrose oil capsules were: TC88%, TG91%, and 44% of lipoprotein. The lipid lowering levels were TC30%, TG67%, and β lipoprotein 76%. Description of evening primrose oil capsules in reducing TC and TG was significantly better than the lipid-lowering group (P <0.05). Evening primrose oil capsules after stopping, no significant rise in blood lipids, blood lipids in some cases continue to decline, and adverse reactions, is a promising lipid-lowering drugs, it is worth promoting the application.